Understanding How Common Medications Affect Your Tears
Millions of people reach for over-the-counter allergy and cold medications without thinking twice. Oral antihistamines help control sneezing, runny noses, and itchy eyes during allergy season. Decongestants relieve stuffy noses and sinus pressure during colds and upper respiratory infections. These medications are widely available, accessible, and generally considered safe for short-term use. However, many people are unaware that these common drugs can significantly affect the eyes by reducing tear production.
The TFOS DEWS III report, a major international review of dry eye science, specifically identifies oral antihistamines and decongestants among the most common yet frequently overlooked triggers for dry eye disease. These medications fall within the report's iatrogenic category, meaning they cause dry eye as a side effect of medical treatment. Understanding this connection gives you the knowledge to protect your eye comfort while still managing your allergy or cold symptoms effectively.
To understand why antihistamines cause dry eye, it helps to know a little about how they work. Oral antihistamines, both older first-generation and newer second-generation versions, block histamine receptors throughout the body to reduce allergy symptoms. This is what stops the sneezing, itching, and runny nose. However, these medications also carry anticholinergic properties, which means they interfere with a broader set of nerve signals beyond just histamine.
Specifically, oral antihistamines block the muscarinic receptors in the lacrimal glands. The lacrimal glands are the small structures located above each eye that produce the watery (aqueous) layer of the tear film. Under normal conditions, your parasympathetic nervous system sends signals through these muscarinic receptors to tell the lacrimal glands to produce tears. When an antihistamine blocks these receptors, it effectively interrupts the communication pathway between the brain and the tear glands. The glands receive a weakened signal, or no signal at all, and tear production drops.
Oral decongestants work by constricting blood vessels throughout the nasal passages to reduce swelling and relieve congestion. However, this vasoconstrictive effect is not limited to the nose. Decongestants can also constrict blood vessels in other tissues, including those that supply the lacrimal glands and the conjunctiva (the thin tissue that lines the inner eyelids and covers the white of the eye).
When blood flow to these structures is reduced, the lacrimal glands receive less of the nutrients and oxygen they need to function at full capacity. The conjunctiva can also become drier as its own moisture-producing cells are affected by the reduced blood supply. Many over-the-counter cold and allergy products combine both an antihistamine and a decongestant in a single pill, which means both mechanisms can work together to reduce your tear production simultaneously.
Clinical research documented in the TFOS DEWS III report demonstrates that the effects of these medications on tear production can be rapid and significant. Studies indicate that taking a single dose of an oral antihistamine can measurably decrease tear production within just a few hours. This is not a subtle or gradual change. Patients commonly experience a noticeable onset of symptoms including a gritty or sandy feeling in the eyes, a sensation that something foreign is on the eye surface, and episodes of blurred vision.
These symptoms occur because the sudden drop in aqueous tear volume disrupts the stability of the entire tear film. Without enough watery fluid to maintain a smooth, even layer over the cornea, the tear film breaks up more quickly between blinks. This leaves patches of the corneal surface temporarily exposed to air, causing irritation, discomfort, and the visual disturbances that many people describe as intermittent blurriness that clears briefly after blinking.
The severity of medication-related dry eye depends significantly on how often and how long you take these drugs. A single dose during a brief cold may cause temporary dryness that resolves once the medication leaves your system. However, patients who take oral antihistamines daily for weeks or months during extended allergy seasons face a more sustained reduction in tear production. Over time, chronic suppression of lacrimal gland activity can lead to a more persistent form of dry eye that takes longer to recover from even after the medication is stopped.
It is also worth noting that many people take these medications seasonally but repeatedly, year after year. Each period of prolonged use subjects the tear system to another round of suppressed function. Patients who have been managing seasonal allergies with daily oral antihistamines for many years may find that their baseline tear production has gradually declined, contributing to dry eye symptoms that seem to linger between allergy seasons.
Who Is Most at Risk for Medication-Related Dry Eye
Patients who rely on a daily oral antihistamine for chronic or seasonal allergies are at the highest risk. The sustained, day-after-day suppression of lacrimal gland signaling means the tear system is under constant reduced output. Even second-generation antihistamines, which are often marketed as less likely to cause drowsiness, still carry anticholinergic effects that affect tear production. The convenience of a once-daily allergy pill can mask the gradual development of dry eye symptoms because the dryness builds slowly over days and weeks.
Many over-the-counter products combine an antihistamine with a decongestant and sometimes additional active ingredients. These combination formulas deliver multiple mechanisms that each independently reduce tear production or affect the tear film. Patients using these products may experience a more pronounced drying effect than they would from either ingredient alone. Reading the active ingredients on the label can help you understand what your medication contains and whether it includes components that affect tear production.
Tear production naturally decreases with age as the lacrimal glands gradually lose some functional capacity. When an older adult takes an oral antihistamine or decongestant, the medication-induced reduction in tear production is added to an already diminished baseline. This combination can push tear volume below the threshold needed for comfortable, healthy eye function. Older adults are also more likely to take multiple medications simultaneously, some of which may carry their own drying effects, compounding the overall impact on the tear system.
If you already experience dry eye symptoms, adding an oral antihistamine or decongestant to your daily routine can significantly worsen your condition. Your tear system is already operating with reduced reserves, and the additional suppression caused by these medications can tip the balance from manageable discomfort to more severe symptoms. If you have a dry eye diagnosis, it is especially important to discuss your allergy and cold medication choices with your eye care provider so they can help you find options that minimize the impact on your eyes.
Contact lenses depend on a stable, adequate tear film to remain comfortable and to maintain clear vision. When oral antihistamines or decongestants reduce tear volume, the tear film beneath and around the contact lens becomes thinner and less stable. This can cause the lens to feel dry, irritating, and uncomfortable. It can also lead to deposits forming on the lens surface more quickly. Contact lens wearers who begin taking these medications may notice that their lenses become uncomfortable within hours of taking the dose.
Women have a higher baseline risk for dry eye disease due to hormonal factors, particularly those associated with hormonal changes during different life stages. When medications that suppress tear production are added to this existing vulnerability, the combined effect can produce more noticeable and bothersome symptoms. Women who take daily oral antihistamines should be particularly attentive to changes in eye comfort.
Managing Dry Eye Caused by Antihistamines and Decongestants
One of the most effective strategies recommended in the TFOS DEWS III guidelines is switching from oral antihistamines to topical anti-allergy eye drops when the primary allergy symptoms affect the eyes. Topical antihistamine eye drops deliver the medication directly to the eye surface where it is needed, targeting the local allergy response without suppressing the lacrimal glands. Because the medication acts locally rather than circulating through the entire body, it does not block the muscarinic receptors in the lacrimal glands and therefore does not reduce tear production.
For patients whose allergy symptoms include significant nasal congestion in addition to eye symptoms, a combination approach may be helpful. Using a topical antihistamine eye drop for the ocular symptoms and a nasal corticosteroid spray for the nasal symptoms can address both areas without relying on oral medications that suppress tear production. Your eye care provider or primary care provider can help you determine the best combination for your specific allergy pattern.
When systemic allergy or cold medication is necessary and cannot be avoided, the TFOS DEWS III guidelines recommend proactively compensating for the reduced tear production by using preservative-free artificial tears. These drops artificially replace the lost aqueous volume that the lacrimal glands are no longer producing at full capacity. Using preservative-free formulations is important because preservatives in some eye drops can cause additional irritation with frequent use, especially on an already compromised eye surface.
The timing of artificial tear use can be strategic. Applying drops shortly before taking your oral antihistamine or decongestant, and then continuing to apply them at regular intervals throughout the day, helps maintain a baseline level of moisture on the eye surface. Many patients find that applying drops every two to four hours provides adequate supplementation during the period when the medication is most actively suppressing tear production.
Being thoughtful about when and for how long you take oral antihistamines and decongestants can reduce their impact on your eyes. If your allergy symptoms are worst in the morning, taking your medication at night may allow peak blood levels to coincide with the time when you are asleep and your eyes are closed, reducing the exposure of the eye surface to the drying effect. Limiting the duration of medication use to only the days when symptoms are most bothersome, rather than taking them continuously throughout the entire allergy season, gives your tear system periodic recovery time.
For cold medications containing decongestants, following the recommended duration of use (typically no more than a few days for most products) helps limit the impact on tear production. If cold symptoms persist beyond the recommended medication duration, consulting your primary care provider about alternative approaches can help you avoid prolonged decongestant exposure.
Environmental modifications can provide meaningful support for your tear film while you are taking medications that reduce tear production. Using a humidifier in your home and workspace adds moisture to the air and slows the evaporation of your already-reduced tear film. Positioning yourself away from direct airflow from fans, air conditioning, and heating vents protects the moisture on your eye surface from being carried away by moving air.
Taking regular breaks during focused visual tasks such as reading or computer work encourages more frequent blinking, which helps spread fresh tears across the eye surface. The 20-20-20 rule is a helpful guideline: every 20 minutes, look at something about 20 feet away for 20 seconds. Wearing wraparound glasses or moisture chamber glasses outdoors on windy or dry days creates a more humid environment around your eyes and shields them from conditions that accelerate tear evaporation.
If you regularly use oral antihistamines or decongestants, periodic comprehensive eye exams can help your eye care provider monitor the health of your tear film and eye surface over time. At Washington Eye Institute, our multidisciplinary ophthalmology and optometry team evaluates tear production, tear film stability, and the condition of the eye surface to detect early signs of medication-related dry eye before symptoms become severe.
These assessments are especially valuable for patients who take these medications seasonally over many years. Tracking changes in your tear function from one visit to the next allows your provider to identify trends and adjust your management plan proactively. If your dry eye requires more advanced treatment, options such as punctal plugs or IPL therapy (intense pulsed light) may be recommended based on a thorough evaluation of your specific condition.
One of the simplest and most effective steps you can take is to keep your healthcare providers informed about all the medications you are taking, including over-the-counter products. Many people do not think to mention allergy pills or cold medications during an eye exam because they seem unrelated to eye health. However, this information helps your eye care provider understand the full picture of factors affecting your tear system.
Similarly, if you have been diagnosed with dry eye, mentioning this to your primary care provider or allergist when discussing allergy management can open the door to alternative treatment approaches that are gentler on your eyes. The best outcomes happen when all members of your care team are aware of how your various treatments interact with each other.
Frequently Asked Questions
Clinical research indicates that a single dose of an oral antihistamine can measurably reduce tear production within a few hours of taking the medication. Many patients notice increased dryness, grittiness, or a foreign-body sensation in the eyes on the same day they take the medication. The speed of onset reflects how quickly the drug reaches systemic levels and begins blocking the muscarinic receptors in the lacrimal glands. The drying effect typically lasts as long as the medication remains active in your system.
Second-generation oral antihistamines were designed to cause less drowsiness than first-generation versions, and they do generally have somewhat reduced anticholinergic effects overall. However, they still carry enough anticholinergic activity to affect lacrimal gland function and reduce tear production. While the degree of drying may be slightly less than with older first-generation antihistamines, second-generation versions are not free from this side effect. If dry eye is a concern, topical antihistamine eye drops remain the preferred alternative regardless of which generation of oral antihistamine you are considering.
For most patients, the dry eye symptoms caused by oral antihistamines and decongestants improve once the medication is discontinued and clears from the body. If you were taking the medication for only a short time, symptoms may resolve within a day or two. However, patients who have used these medications daily for extended periods may find that their tear system takes longer to recover its full production capacity. In some cases, the prolonged suppression may have contributed to a baseline shift that benefits from ongoing tear film support even after the medication is stopped.
Yes. Topical antihistamine eye drops and preservative-free artificial tears can be used together as part of a comprehensive approach to managing both allergy symptoms and dry eye. It is generally recommended to wait about five to ten minutes between applying different types of eye drops to allow each one to be properly absorbed. Your eye care provider can help you establish a schedule that coordinates both types of drops for the best results.
When checking over-the-counter product labels, look for active ingredients that belong to the antihistamine or decongestant categories. Common oral antihistamine ingredients include diphenhydramine, chlorpheniramine, loratadine, cetirizine, and fexofenadine. Common oral decongestant ingredients include pseudoephedrine and phenylephrine. Combination products may list several of these ingredients together. If you are unsure whether a product contains ingredients that could affect your tear production, your pharmacist can help you identify the components and suggest alternatives that may be less likely to cause dryness.
Scheduling a visit with your eye care provider before or at the beginning of allergy season is an excellent proactive step, especially if you have experienced dry eye symptoms during previous allergy seasons. Your provider can evaluate your current tear film health, discuss your allergy medication options, and help you develop a plan that controls your allergy symptoms while minimizing the impact on your eyes. This is also a good time to stock up on preservative-free artificial tears so you are prepared to supplement your tear film from the very first day you need allergy medication.